Perspective Therapeutics, Inc.
CATX
$3.46
-$0.22-5.98%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.95M | -73.47M | -67.58M | -52.08M | -47.32M |
| Total Depreciation and Amortization | 3.55M | 2.81M | 2.44M | 999.00K | 608.00K |
| Total Amortization of Deferred Charges | 7.00K | 7.00K | 7.00K | 7.00K | 7.00K |
| Total Other Non-Cash Items | 28.72M | 27.00M | 26.14M | 15.03M | 14.19M |
| Change in Net Operating Assets | -1.38M | -468.00K | 30.31M | 44.25M | 27.24M |
| Cash from Operations | -64.78M | -53.72M | -18.29M | -696.00K | -14.17M |
| Capital Expenditure | -50.01M | -48.98M | -53.40M | -38.87M | -9.39M |
| Sale of Property, Plant, and Equipment | 335.00K | 335.00K | 335.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -119.97M | -125.26M | -162.57M | -38.25M | -38.23M |
| Cash from Investing | -169.64M | -177.20M | -218.93M | -80.42M | -50.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -54.00K | -41.00K | -40.00K | -40.00K | -45.00K |
| Issuance of Common Stock | 10.78M | 10.63M | 166.98M | 167.35M | 166.73M |
| Repurchase of Common Stock | -287.34M | -287.34M | -287.34M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 288.06M | 288.06M | 288.06M | 0.00 | 0.00 |
| Cash from Financing | 11.08M | 133.03M | 289.39M | 289.39M | 288.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -223.34M | -97.89M | 52.16M | 208.28M | 223.69M |